Gender‐incompatible liver transplantation is not a risk factor for patient survival

Liver International - Tập 29 Số 2 - Trang 196-202 - 2009
Frank Lehner1, Thomas Becker, Jürgen Klempnauer, Jürgen Borlak
1Department of General, Visceral and Transplantation Surgery, Hannover Medical School, Hannover, Germany

Tóm tắt

AbstractBackground/Aims: Clinical data may be suggestive for differences in patient survival in gender‐incompatible orthotopic liver transplantation (OLT), but findings are inconsistent and are putatively linked to circulating hormones. We therefore investigated patient survival as well as metabolism of steroids to identify possible causes of improved graft survival in gender‐mismatched OLT.Methods: We examined our single‐centre database of 1355 recipients of first liver transplants for overall patient survival by non‐parametric and parametric analysis of multivariance taking the age of recipient and donor, ischaemia time, underlying liver disease and the time period of transplantation into account. Furthermore, the metabolism of androgens in gender‐incompatible OLT was studied in cultures of primary human hepatocytes obtained from male and female patients.Results: Unlike previous studies we were unable to determine overall significant differences in patient survival in gender‐incompatible OLT, even though a statistically significant improved patient survival was observed when male donor livers were transplanted into female recipients in univariant analysis (P=0.047). However, when the overall patient management was taken into account no difference in survival was determined in multivariant analysis. Importantly, the metabolism of testosterone did not differ between male and female hepatocyte cultures, except for the production of 6‐α‐hydroxy‐testosterone (P<0.001).Conclusions: Taken collectively, clinical observations may tend to suggest a slightly improved patient survival in gender‐incompatible OLT but this cannot be explained on the bases of androgen metabolism. Overall, we view gender‐incompatible liver transplantation not to be a confounder in patient survival after OLT.

Từ khóa


Tài liệu tham khảo

10.1016/j.lts.2003.09.018

10.1111/j.1600-6143.2006.01501.x

Maluf DG, 2006, Utilization of extended donor criteria liver allograft, is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient?, 82, 1653

10.1097/01.sla.0000234896.18207.fa

10.1111/j.1600-6143.2007.01887.x

De Santo LS, 2002, The impact of gender on heart transplantation outcomes, a single center experience, 3, 419

10.1159/000087920

Wittnich C, 2004, Lower liver transplant success in females, gender differences in metabolic response to global ischemia, 36, 1485

10.1002/hep.1840220622

10.1053/jlts.2002.33457

10.1097/01.ASN.0000030078.74889.69

10.1097/01.tp.0000269090.90068.0f

Nair S, 2002, Effect of race on outcome of orthotopic liver transplantation, a cohort study, 359, 287

10.1016/S0303-7207(00)00401-9

10.1210/endo-111-5-1692

10.1016/S0041-008X(02)00075-3

10.1016/S0006-2952(00)00537-2

Sanfey H., 2005, Gender‐specific issues in liver and kidney failure and transplantation, a review, 14, 617

10.1097/00007890-199612270-00017

10.1007/BF01308608

Burroughs AK, 2006, 3‐month and 12‐month mortality after first liver transplant in adults in Europe, predictive models for outcome, 367, 225

10.1111/j.1432-2277.2004.tb00464.x

Dahm F, 2005, Small‐for‐size syndrome after partial liver transplantation, definition, mechanisms of disease and clinical implications, 5, 2605

Perkins JD., 2006, Using extended criteria donor (ECD) livers, three strikes and you're almost out, 12, 1554

10.1097/00007890-199809150-00009

10.1016/j.healun.2005.11.456

10.1016/j.healun.2006.01.012

10.1016/j.transproceed.2004.07.046

10.1002/lt.20408

10.3748/wjg.v12.i22.3537

10.1001/archsurg.138.7.727

Reckelhoff JF, 2005, Testosterone supplementation in aging men and women, possible impact on cardiovascular-renal disease, 289, F941

10.1161/hq0302.104515

10.1034/j.1600-0676.2003.00811.x

10.1210/edrv.23.1.0456

10.1016/j.jss.2005.04.017

10.1056/NEJMra052529

10.1152/ajpcell.00203.2007

10.1016/S0531-5565(03)00036-6